Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: A phase 1 study

Ronan T. Swords, Harry P. Erba, Daniel J. Deangelo, Dale L. Bixby, Jessica K. Altman, Michael Maris, Zhaowei Hua, Stephen J. Blakemore, Hélène Faessel, Farhad Sedarati, Bruce J. Dezube, Francis J. Giles, Bruno C. Medeiros

Research output: Contribution to journalArticlepeer-review

169 Scopus citations

Fingerprint

Dive into the research topics of 'Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: A phase 1 study'. Together they form a unique fingerprint.

Medicine & Life Sciences